Sonia Garcia

Does TMS therapy work? For many people whose depression has not responded to antidepressants, yes, and the research shows how many. The FDA cleared transcranial magnetic stimulation (TMS) for major depressive disorder in 2008 on the strength of sham-controlled trials, and more than a decade of real-world outcome data has followed. What the evidence does not support is an unqualified "TMS works." Outcomes vary from person to person, the numbers depend on how you define success, and the people who benefit most share a recognizable profile.

‍

Start with the definitions, because every statistic below depends on them.

What "Works" Means: Response vs. Remission

Depression research measures success on rating scales, and two thresholds matter.

‍

Response means a meaningful reduction in symptoms, usually defined as a 50% or greater drop in the score on a standard depression scale. Someone who responds feels noticeably better but may still have symptoms.

‍

Remission means the score falls below the scale's cutoff for depression. Symptoms are largely gone. Remission is the goal of treatment, and it is the harder bar to clear.

‍

Two more details shape every TMS success rate you will read. The scale matters: clinician-rated scales and patient questionnaires produce different numbers for the same group of people. And the population matters. TMS is studied almost entirely in people whose depression has already failed to respond to medication, so its rates should be compared with other treatments for that same group, not with a first antidepressant.

What the Clinical Evidence Shows

One of the key trials confirming TMS's effect was a randomized, sham-controlled study led by Mark George and published in Archives of General Psychiatry in 2010. It enrolled 199 adults with major depression who were not taking antidepressants, with 190 included in the analysis. During the blinded phase, 14.1% of people receiving active TMS reached remission, compared with 5.1% receiving sham stimulation. The odds of remission were 4.2 times higher with real treatment, and the number needed to treat was 12.

‍

Those figures look modest next to many TMS marketing pages. The blinded phase was short, the remission bar strict, and a sham-controlled design exists to prove an effect is real, not to show the best a treatment can do in practice. On that goal, it succeeded.

‍

Real-world outcomes come from a different kind of study. In 2012, Linda Carpenter and colleagues published a multisite observational study in Depression and Anxiety covering 307 outpatients treated at 42 clinical TMS practices across the United States. These patients had already tried an average of 2.5 antidepressants at adequate dose and duration without satisfactory improvement. By the end of treatment, 58% had responded and 37.1% were in remission on the clinician-rated scale. On the PHQ-9, a self-report questionnaire, 56.4% responded and 28.7% reached remission.

‍

Our own framing for patients is deliberately conservative: roughly half of people respond and roughly one in three reach remission, and those figures describe people who had not benefited from four or more antidepressants. So how effective is TMS for depression? For depression that has resisted medication, it helps about half of the people who complete a standard course, and it clears depression for about a third.

‍

One clarification about higher numbers you may have seen. Remission rates of 70% or 80% come from newer accelerated protocols, many sessions per day over about a week guided by brain imaging, in small early trials. The FDA has cleared a rapid-acting form of TMS, as the National Institute of Mental Health notes, but we do not offer accelerated protocols, and the figures in this article describe the standard daily course our clinics provide.

TMS Compared to Other Depression Treatments

Antidepressant medication remains first-line, and TMS is typically considered after it. Compared with switching to yet another medication, TMS acts on the brain directly rather than through the bloodstream, which is why it does not cause weight gain, sexual side effects, or sedation.

‍

Electroconvulsive therapy (ECT) produces larger and faster symptom reduction in head-to-head research, but it requires general anesthesia and can affect memory around the time of treatment, so it is reserved for severe or urgent situations. Esketamine (Spravato) and ketamine can act within days rather than weeks, with a different monitoring burden and a different side-effect profile. None of these is universally better. They suit different clinical pictures, and we compare each pairing in depth in dedicated articles.

Who Is Most Likely to Benefit

The evidence points to a consistent profile of the person who does well with TMS. It matches the eligibility criteria we use, which also track what insurers require for authorization:

‍

• A confirmed diagnosis of major depressive disorder. TMS is cleared for MDD, not for every kind of low mood, and getting the diagnosis right comes first. If you are unsure how your diagnosis fits, our guide to major depressive disorder vs. persistent depressive disorder explains the distinction.
• Multiple antidepressants from different classes that did not bring adequate improvement.
• Psychotherapy that was tried and did not bring enough relief.
• No medical contraindications. TMS uses a strong magnetic field, so we screen for a history of seizures or epilepsy, metal in the head outside the mouth, implanted devices such as pacemakers, and a history of stroke, neurosurgery, or brain injury. Pregnancy calls for individualized planning with your obstetric and psychiatric team. Ordinary dental fillings are not a problem.
• The ability to commit to a daily session schedule for several weeks.

‍

Notice what is not on the list: how many years you have spent on medication. More than half of the Carpenter study's patients responded after multiple failed medication trials.

How Long It Takes to See Results

TMS is cumulative. A single session produces nothing you would notice; the benefit builds as repeated stimulation changes activity in the mood circuits being targeted. At our clinics, a full course of TMS means 20 to 30 weekday sessions over roughly four to six weeks.

‍

When improvement shows up varies. Some people notice sleep, energy, or concentration shifting in the second or third week, often before their mood lifts. Others feel little change until the final stretch of the course. Both patterns are normal, and neither predicts the final outcome well, which is why progress is judged with symptom rating scales rather than a mid-course impression. The most common mistake is writing TMS off after a handful of sessions.

What Happens If TMS Doesn't Work?

It is a fair question to ask before you start, and the answer is not "you are out of options."

‍

If symptom scores have not moved by the later part of the course, a psychiatrist reassesses rather than simply stopping. The treatment plan can be adjusted, including the stimulation parameters or the length of the course. Medication can be changed or added, since TMS and medication are often combined. Psychotherapy can be intensified. And other options for treatment-resistant depression remain on the table, including esketamine and, for severe or urgent depression, ECT.

‍

Partial response is its own category: a 30% drop in symptoms is not a treatment failure, and it often shapes what comes next. People who responded well to a first course can also be treated again if depression returns.

‍

What happens if TMS doesn't work is, in the end, what happens at every stage of treating difficult depression: the plan changes, and the person stays in care. If you are having thoughts of suicide at any point, call or text 988 to reach the Suicide and Crisis Lifeline.

What TMS Does Not Do

TMS is a specific tool, and its limits are as well defined as its strengths.

‍

It does not work for everyone. About half of people with medication-resistant depression respond, which means about half do not.

‍

It is not a first-line treatment. In practice, and in insurers' criteria, TMS comes after antidepressant trials, not instead of them.

‍

It is not a general-purpose brain treatment. The FDA clearances are specific: major depressive disorder since 2008 and obsessive-compulsive disorder since 2018, plus a small number of narrowly defined uses. Anxiety disorders and PTSD are being studied, but those uses are not cleared. At our clinics we currently provide TMS for major depressive disorder.

‍

It is not a cure. Remission is a realistic goal, but depression can return, and TMS belongs inside ongoing care rather than serving as a one-time fix.

What to Expect During a Course of Treatment

The practical side is simpler than most people expect.

‍

Treatment begins with a screening visit of 30 to 60 minutes to confirm the diagnosis, review your treatment history, and check for contraindications. Sessions then run Monday through Friday, 30 to 40 minutes each. You sit in a chair, awake, while a magnetic coil rests against your scalp and delivers pulses in short trains. It feels like tapping. With no anesthesia or sedation, you drive yourself home and go straight back to your day.

‍

Side effects are mostly local and mostly early: scalp discomfort at the coil site and headache, both of which typically clear within the first week. Because nothing enters your bloodstream, TMS does not cause the weight gain, sexual dysfunction, stomach upset, dry mouth, or sedation that antidepressants can. The one serious risk, seizure, is exceedingly rare, and the screening process exists to keep it that way.

Talking to a Psychiatrist About Whether TMS Is Right for You

Population statistics tell you what TMS does for people like you. They cannot tell you what it will do for you. That question gets answered in an evaluation, where a psychiatrist reviews your diagnosis, medication history, health, and goals, and tells you plainly whether TMS is a reasonable next step.

‍

At Amae, TMS is one part of an integrated care model in which psychiatry, therapy, primary care, and peer support come from the same team, so a course of TMS fits into your broader care rather than running alongside it. We provide it in Los Angeles, Los Altos, and San Mateo, all commercial insurance plans are accepted alongside cash pay, and prior authorization is handled by our intake team. To find out where you stand, schedule an evaluation with an Amae psychiatrist.

Frequently Asked Questions

What percentage of people does TMS work for?

In a major multisite real-world study, 58% of patients responded and 37% reached remission on clinician ratings after a standard course. Those patients had already tried an average of 2.5 antidepressants without adequate relief, so the numbers describe treatment-resistant depression, not depression in general. Our own conservative framing is that about half respond and about one in three reach remission.

How soon does TMS start working?

Gradually, over the course rather than after a single session. Some people notice changes in sleep, energy, or focus within the first two or three weeks, while others see improvement only near the end of the four-to-six-week course. Neither pattern reliably predicts the final result.

Does TMS work for everyone?

No. Like every treatment for depression, TMS produces a range of outcomes, and roughly half of people with medication-resistant depression do not respond. That is why a psychiatrist tracks symptoms during the course and adjusts the plan if progress stalls.

Is TMS FDA-approved or still experimental?

TMS is FDA-cleared, not experimental. Clearance for major depressive disorder came in 2008 and for obsessive-compulsive disorder in 2018, both on the basis of controlled clinical trials. Uses such as anxiety disorders and PTSD are still at the research stage and are not cleared.

What happens if TMS doesn't work for me?

A psychiatrist reassesses and lays out next steps. Those can include adjusting the treatment plan, combining TMS with medication changes or psychotherapy, or considering other treatment-resistant depression options such as esketamine or ECT. Not responding to TMS does not mean nothing else will work.

How long do the effects of TMS last?

It varies. Improvement often lasts well beyond the end of the course, some people need a maintenance plan or a repeat course, and the timing differs from person to person. Durability deserves its own discussion, and it is one to have with your psychiatrist as you approach the end of a course.

‍

Citations

1. George MS, Lisanby SH, Avery D, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Archives of General Psychiatry. 2010. https://pubmed.ncbi.nlm.nih.gov/20439832/ (Tier 1)
2. Carpenter LL, Janicak PG, Aaronson ST, et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depression and Anxiety. 2012. https://pubmed.ncbi.nlm.nih.gov/22689344/ (Tier 1)
3. Micallef-Trigona B. Comparing the effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in the treatment of depression: a systematic review and meta-analysis. Depression Research and Treatment. 2014. https://pubmed.ncbi.nlm.nih.gov/25143831/ (Tier 1)
4. National Institute of Mental Health. Brain Stimulation Therapies. https://www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapies (Tier 2)
5. 988 Suicide and Crisis Lifeline. https://988lifeline.org (Tier 2)

‍

f you are comparing TMS, ketamine, and Spravato for depression, you have probably reached the point where standard antidepressants have not done enough. All three are evidence-based options for treatment-resistant depression, and beyond that they have little in common. TMS is a course of magnetic stimulation delivered while you sit awake in a chair. Ketamine is an anesthetic given by IV, used off-label for depression. Spravato is a nasal spray made from esketamine, one of the two mirror-image forms that make up ketamine, with its own FDA approval and its own rulebook.

‍

None of the three is universally better. They differ in mechanism, speed, setting, and monitoring, and the right one depends on your clinical history and how you respond. Treatment-resistant depression generally means depression that has not adequately improved after at least two antidepressants taken at a proper dose for long enough, and that is the group where all three are most often used.

What Is TMS?

Transcranial magnetic stimulation uses a coil placed against the scalp to deliver focused magnetic pulses to the left dorsolateral prefrontal cortex, a region involved in mood regulation. The FDA first cleared TMS for major depressive disorder in 2008, according to the National Institute of Mental Health. It is delivered in an office, with no anesthesia and no medication.

‍

Our standard TMS course runs 20 to 30 daily sessions over four to six weeks, each 30 to 40 minutes long. You stay awake throughout and drive yourself home afterward. In real-world outcome data from 42 U.S. practices, more than half of patients with medication-resistant depression responded to a standard course, and more than a third reached remission.

What Is Ketamine Therapy?

Ketamine has been an FDA-approved anesthetic since 1970. Its use for depression is off-label: prescribed for a purpose the FDA has not formally approved, which is legal and common in medicine but leaves the safeguards less standardized. It is usually given as an IV infusion in a monitored clinic, as a series of sessions over a few weeks.

‍

Ketamine blocks the NMDA receptor, a glutamate receptor, rather than acting on serotonin like standard antidepressants, and that difference is thought to explain its speed. In a landmark 2006 trial, 18 people with treatment-resistant depression received a single infusion of 0.5 mg/kg, and their symptoms improved significantly within 110 minutes. By the next day, 71% had responded and 29% were in remission. One week later, 35% still met the response threshold. Rapid, real, and often short-lived.

‍

The catch is in the monitoring. Ketamine causes dissociation, a sense of detachment from your body or surroundings, plus sedation and blood pressure rises during and after the infusion, so you are observed until those effects pass and cannot drive that day. In a 2017 consensus statement in JAMA Psychiatry, an American Psychiatric Association task force found the evidence for rapid antidepressant effects convincing but the studies small, the longer-term efficacy data lacking, and the safety data on repeated dosing limited.

What Is Spravato (Esketamine)?

Ketamine is a mixture of two mirror-image molecules. Spravato is esketamine, one of those two, delivered as a nasal spray. Unlike IV ketamine, it has FDA approval for depression. The original approval came in March 2019 for treatment-resistant depression alongside an oral antidepressant, a second indication followed for adults with major depressive disorder and acute suicidal thoughts or behavior, and in January 2025 the FDA approved Spravato as a standalone monotherapy for treatment-resistant depression, with no oral antidepressant required, per the current prescribing information.

‍

That approval comes with a rulebook. Spravato can only be given at a setting certified under a Risk Evaluation and Mitigation Strategy (REMS) program: you take the spray under supervision, you are monitored for at least two hours before an assessment clears you to leave, and you cannot drive until the next day after a restful sleep. Its label carries a boxed warning for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors in younger patients.

‍

So is Spravato the same as ketamine? Related, not identical: same molecular family, same receptor, similar rapid onset and dissociative effects, but a different route, a formal FDA indication, and mandatory monitoring rules that off-label ketamine does not carry. For most people comparing TMS vs Spravato, those rules and insurance coverage are the practical differences that matter.

TMS vs Ketamine vs Spravato: Side-by-Side Comparison

Onset and Duration of Effect

Speed is the clearest dividing line. TMS builds gradually, and many people do not notice a clear change until the second or third week or later. Ketamine and Spravato can shift symptoms within hours to days.

‍

Speed and staying power are different things. Ketamine's effect after a single infusion often fades within a week or two, which is why it is given as a series with maintenance dosing. Spravato starts at twice a week and tapers, with the need for continued treatment reassessed along the way. Research on durability is still developing for all three, and none should be described as permanent.

Side Effects and Safety Considerations

TMS side effects are local and short-lived: scalp discomfort where the coil sits, headache, and sometimes brief lightheadedness or facial muscle twitching during the pulses. These usually settle within the first week, and because nothing enters the bloodstream there is no weight gain, sexual dysfunction, or sedation. Seizure is the one serious risk, exceedingly rare, and TMS is not used in people with a seizure history, metal in the head, or implanted electronic devices.

‍

Ketamine and Spravato share a different profile. The most common reactions to Spravato in trials were dissociation, dizziness, nausea, sedation, vertigo, numbness, anxiety, lethargy, increased blood pressure, vomiting, feeling drunk, and headache. Those effects peak in the hours after dosing, which is what the monitoring window is for, and both drugs carry a potential for misuse that shapes who is a candidate. Each option has its own screening, and a contraindication to one does not rule out the others.

Cost and Insurance

For TMS, most commercial insurers cover treatment for major depressive disorder once eligibility criteria are met, typically a confirmed diagnosis and documented antidepressant trials without adequate relief. Prior authorization is standard. For TMS we take all commercial insurance plans, cash pay is available, and authorization is something our intake team manages for you.

‍

Spravato is more commonly covered than off-label ketamine because it has an FDA indication insurers can write criteria around, though prior authorization and documentation of failed antidepressant trials are typically required. Ketamine infusion coverage varies widely, and many clinics are self-pay. Published cost estimates vary so much by dose, frequency, and insurance status that a single dollar figure would mislead; ask each provider and your insurer directly.

Can These Treatments Be Combined?

Sometimes, and the research is early. A 2024 systematic review found six published studies on combining TMS with ketamine, mostly case reports plus one retrospective review and one small pilot, and reported substantial and sustained improvement with generally mild side effects. The authors also said the designs were too varied and the samples too small for firm conclusions, and called for randomized trials.

‍

In practice, TMS and Spravato are sometimes used one after the other. Combining any of these is a clinical judgment a psychiatrist makes from your history, not a general recommendation, and the more common pattern is to use one, assess the response, then decide.

Choosing Between Them: What Influences the Decision

A psychiatrist weighing these options usually works through a short list:

‍

• Treatment history. Which antidepressants, at what doses, for how long, and whether psychotherapy has been tried.
• How urgently relief is needed. When symptoms are severe or suicidal thoughts are present, a faster-acting option may take priority, alongside care for suicidal thoughts.
• Tolerance for the experience. Dissociation and a two-hour monitored window, versus a daily half-hour appointment for several weeks with no drug effects.
• Practical constraints. Whether you can get to daily sessions, whether someone can drive you home after Spravato or ketamine, and what your insurance will authorize.
• Health factors. Seizure history, metal implants, blood pressure, and any history of substance misuse each rule options in or out.
• What else is in place. Any of the three works better inside ongoing psychiatric care and therapy than as a standalone fix.

Making the Decision With an Integrated Care Team

TMS, ketamine, and Spravato are tools, and tools do their best work inside a plan: a psychiatrist who knows your history, a therapist working alongside the biological treatment, and a team that notices when the plan needs to change.

‍

That is how we work. At Amae, our one-team care model combines psychiatry, therapy, primary care, and peer support, and TMS and Spravato are available through our Los Angeles and Bay Area clinics as part of that care. If you have been through the antidepressant cycle and want a clear, unhurried look at what comes next, talk with an Amae psychiatrist about your options. If you are in crisis or thinking about suicide, call or text 988 now.

Frequently Asked Questions

What is the difference between TMS and ketamine for depression?

TMS stimulates the brain with magnetic pulses over a course of daily outpatient sessions, with no drug, no sedation, and no monitoring afterward. Ketamine is a medication that acts on NMDA receptors, given by infusion or, as esketamine, by nasal spray, with monitored sedation and dissociation and often faster but shorter-lived effects.

Is Spravato the same as ketamine?

Related but not identical. Spravato is esketamine, the S-enantiomer of the ketamine molecule, delivered as an FDA-approved nasal spray under a required monitoring program. Ketamine infusions use the full ketamine compound and are prescribed off-label for depression, without an FDA indication for that use.

Is Spravato only approved with an antidepressant?

Not anymore. The original 2019 approval was for use alongside an oral antidepressant, and in January 2025 the FDA also approved Spravato as a standalone monotherapy for adults with treatment-resistant depression. Whether it is used alone or with an antidepressant is a decision your psychiatrist makes based on your situation.

Which works faster, TMS or Spravato?

Spravato. Esketamine and ketamine can produce symptom change within hours to days, while TMS builds gradually across a four-to-six-week course. Faster onset does not mean more durable improvement, and both durability and side effects belong in the comparison.

Can TMS and Spravato be used together?

Sometimes, as a clinical decision made with a psychiatrist based on your individual history. Both can be part of a broader treatment-resistant depression plan alongside medication and therapy, and the evidence on combining them is still early.

Is ketamine or Spravato covered by insurance?

Spravato is more commonly covered, because it has an FDA indication insurers can build criteria around, though prior authorization and proof of failed antidepressant trials are usually required. Coverage for off-label ketamine infusions varies widely and is often self-pay. Confirm with the provider and your insurer before starting.

‍

Citations

1. National Institute of Mental Health. Brain Stimulation Therapies. https://www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapies (Tier 2)
2. Carpenter LL, Janicak PG, Aaronson ST, et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depression and Anxiety. 2012. https://pubmed.ncbi.nlm.nih.gov/22689344/ (Tier 1)
3. Zarate CA, Singh JB, Carlson PJ, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry. 2006. https://pubmed.ncbi.nlm.nih.gov/16894061/ (Tier 1)
4. Sanacora G, Frye MA, McDonald W, et al. A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry. 2017. https://pubmed.ncbi.nlm.nih.gov/28249076/ (Tier 1)
5. U.S. Food and Drug Administration. Drugs@FDA: SPRAVATO (esketamine), NDA 211243, approval history. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211243 (Tier 2)
6. U.S. Food and Drug Administration. SPRAVATO (esketamine) nasal spray prescribing information, revised January 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211243s016lbl.pdf (Tier 2)
7. Arubuolawe OO, Folorunsho IL, Busari AK, et al. Combination of transcranial magnetic stimulation and ketamine in treatment-resistant depression: a systematic review. Cureus. 2024. https://pubmed.ncbi.nlm.nih.gov/39156335/ (Tier 1, small-study review)
8. 988 Suicide and Crisis Lifeline. https://988lifeline.org (Tier 2)

‍

Mental health care in Raleigh has expanded significantly in recent years, but more options doesn’t make the choice easier, it makes clarity about what you need more important. The right clinic depends on your diagnosis, how much support you need, and what your insurance covers.

Mental health care in Raleigh, NC ranges from large multi-location networks to academic medical centers to small telehealth practices, and the right choice depends on what you are actually dealing with. Someone looking for weekly therapy for anxiety needs something very different from someone stabilizing a first psychotic episode, and the Triangle has clinics built for each. This guide organizes the area’s leading clinics by what they do, then covers provider types, conditions, telehealth, insurance, and the practical steps to get started.

What to Look for in a Mental Health Clinic in Raleigh

A few factors separate a good fit from the wrong one:

–  Evidence-based treatment. Look for established approaches: CBT, DBT, and medication management, backed by clinicians trained to deliver them.

–  Team composition. Behavioral health in Raleigh, NC is delivered by different provider types: psychiatrists, therapists (LCSW, LCMHC), nurse practitioners, and peer support. Integrated clinics coordinate them under one team.

–  Conditions treated. Some clinics handle complex or co-occurring conditions; others focus on general anxiety and depression. Match the clinic to your diagnosis.

–  Insurance. Confirm in-network status with your plan, whether that is Blue Cross Blue Shield of North Carolina, Aetna, Cigna, NC Medicaid, or Alliance Health. The same visit can cost very differently depending on your coverage.

–  In-person vs. telehealth. Most Raleigh clinics now offer both; decide which suits you before booking.

–  Wait times. New-patient availability ranges from same-week to months out, especially at academic centers. Ask before you commit, because a shorter path to care matters when symptoms are acute.

Best Mental Health Clinics in Raleigh, NC

Raleigh’s clinics fall into distinct categories, each built for a different need: integrated care for serious mental illness, large outpatient networks, therapy-focused practices, integrated substance-use and primary care, telehealth psychiatry, and academic medical centers. The best clinic is the one whose category fits your situation, so the providers below are grouped that way rather than ranked against each other.

Details were verified from each provider as of 2026; confirm current specifics directly, since programs and insurance networks change.

Amae Health: Integrated Care for Adult Complex Mental Illness

At our Raleigh clinic at 4000 Wake Forest Road, Suite 200, Amae Health provides integrated outpatient care for adults living with severe and complex mental illness, delivered in collaboration with leading academic medical centers including NewYork-Presbyterian, Cedars-Sinai, and Mass General Brigham. We treat schizophrenia, schizoaffective disorder, first-episode psychosis, major depressive disorder, bipolar disorder, suicidal thoughts, and co-occurring conditions.

The difference is the team, not any single service. Every patient works with a coordinated group under one roof: psychiatrists for medication management, therapists delivering integrated CBT and DBT, group therapy, peer support specialists, health coaches, and a registered dietitian focused on nutrition, exercise, and sleep. That structure is built for conditions that need more than a single weekly appointment can offer.

–  Specialties: Schizophrenia, first-episode psychosis, schizoaffective disorder, major depressive disorder, bipolar disorder, suicidal thoughts, co-occurring conditions

–  Care model: Integrated psychiatry, CBT and DBT therapy, group therapy, peer support, and health coaching

–  Insurance: Blue Cross Blue Shield of North Carolina, Aetna, Cigna/Evernorth, and Alliance Medicaid; same-day appointments available

–  Phone: (984) 849-4342

–  Best for: Adults with serious or complex mental illness who want fully integrated, psychiatrist-led care

Mindpath Health: Large Multi-Location Outpatient Network

Mindpath Health is a large outpatient mental health provider with locations across the Triangle and North Carolina, including Raleigh. It offers psychiatry, therapy, medication management, and telehealth for adults, children, and adolescents, plus interventional options like TMS and Spravato through a dedicated department. Its scale translates to broad availability across conditions and locations, often with shorter waits for a first appointment.

–  Specialties: Depression, anxiety, ADHD, bipolar disorder, PTSD, OCD, and more, across all ages

–  Care model: Multi-location outpatient network, in-person and telehealth

–  Best for: People who want broad access, multiple locations, and interventional psychiatry options

Ellie Mental Health: Therapy-Focused Outpatient Care

Ellie Mental Health’s Raleigh clinic at 2709 Blue Ridge Road, Suite 190, is a therapy-first practice. Its team of licensed therapists and counselors provides individual, couples, family, and trauma-informed therapy, in person and online, with extended weekday and Saturday hours. This is talk therapy rather than intensive psychiatric programming.

–  Specialties: Anxiety, depression, life transitions, trauma, and mood concerns

–  Care model: Outpatient individual, couples, and family therapy

–  Insurance: In-network with most major plans including Medicaid, plus sliding-scale fees

–  Best for: People seeking talk therapy in a flexible, therapy-focused setting

The Carter Clinic: Integrated Substance Use and Primary Care

The Carter Clinic is a North Carolina practice with multiple locations, including Raleigh, that combines mental health, substance use recovery, and primary care. It provides dual-diagnosis treatment for co-occurring conditions, medication-assisted treatment for opioid use disorder, and intensive outpatient options, alongside routine primary care.

–  Specialties: Co-occurring mental health and substance use, primary care

–  Care model: Integrated behavioral health, addiction recovery, and primary care, in person and telehealth

–  Insurance: Accepts most plans, including Medicaid and Medicare, with sliding-scale fees

–  Best for: People managing substance use alongside a mental health condition

Apogee Behavioral Medicine: General Outpatient Psychiatry and Therapy

Apogee Behavioral Medicine’s Raleigh clinic at 7200 Creedmoor Road, Suite 200, offers psychiatry and counseling in person and via telehealth. Services include psychiatric evaluations, medication management, CBT, and psychodynamic therapy for anxiety, mood disorders, ADHD, and depression.

–  Specialties: Anxiety, depression, ADHD, OCD, PTSD, bipolar disorder

–  Care model: Outpatient psychiatry and therapy, in-person and telehealth

–  Insurance: Accepts most major plans, plus Medicare and Medicaid

–  Best for: Adults seeking general outpatient psychiatry and therapy in North Raleigh

Raleigh Wellness & Behavioral Health: Telehealth Psychiatry

Raleigh Wellness & Behavioral Health is a virtual-only outpatient psychiatry practice serving patients across North Carolina. Its team of physician assistants and nurse practitioners provides psychiatric evaluations and medication management for depression, anxiety, bipolar disorder, ADHD, PTSD, and OCD, with some same-week availability for new patients.

–  Specialties: Depression, anxiety, bipolar disorder, ADHD, PTSD, OCD

–  Care model: Telehealth-only psychiatric evaluation and medication management

–  Best for: Adults who want convenient, medication-focused psychiatric care by telehealth

Duke Health Psychiatry: Academic Medical Center

Duke Health provides academic psychiatric care across the Raleigh-Durham area, including Duke Behavioral Health North Durham, which brings outpatient, inpatient, and ECT services together in one building. Duke offers psychiatric consultation, medication management, individual and group psychotherapy, and brain stimulation options, in person and by telehealth, with the subspecialty depth of an academic medical center. As with most academic centers, the tradeoff is that intake can take longer than at a private practice.

–  Specialties: Complex and treatment-resistant presentations across the full range of conditions

–  Care model: Academic medical center, outpatient and telehealth

–  Best for: Patients with complex or treatment-resistant conditions who want academic-center care

Types of Behavioral Health Providers in Raleigh, NC

Different provider types offer different services. Knowing the difference helps you find the right fit faster.

Psychiatrists

Psychiatrists are medical doctors who diagnose mental health conditions, prescribe and manage medication, and sometimes provide therapy. Psychiatry in Raleigh, NC does not require a referral, and psychiatrists are the right starting point when medication management is central to treatment.

Therapists and Counselors (LCSW, LCMHC)

Therapists provide talk therapy, including CBT, DBT, and trauma-informed approaches, but cannot prescribe medication. They are the most common outpatient providers in Raleigh. Many people see both a therapist and a psychiatrist, or a clinic that coordinates both.

Psychiatric Nurse Practitioners and Physician Assistants (PMHNP, PA-C)

Psychiatric nurse practitioners and physician assistants can diagnose and prescribe in North Carolina. They are common across Raleigh outpatient and telehealth practices and often work alongside psychiatrists in integrated care teams.

Conditions Treated at Mental Health Clinics in Raleigh

Most outpatient clinics treat a range of conditions, though some specialize:

–  Depression and treatment-resistant depression. A depression treatment center in Raleigh with interventional options like TMS or Spravato can help when standard antidepressants have not worked.

–  Anxiety disorders, including generalized anxiety, panic disorder, social anxiety, and OCD.

–  Bipolar disorder. Best managed at integrated clinics with coordinated psychiatry and therapy.

–  ADHD. Assessment and medication management are widely available across Raleigh clinics.

–  PTSD and trauma. Look for trauma-informed therapy or clinicians trained in CPT or EMDR.

–  Schizophrenia, schizoaffective disorder, and first-episode psychosis. These benefit from specialized, structured psychiatric support.

–  Co-occurring substance use and mental health conditions, best treated together by an integrated team.

In-Person vs. Telehealth Mental Health Care in Raleigh

Most Raleigh clinics now offer both in-person and telehealth care, and the right choice depends on the situation. Telehealth works well for ongoing medication management and continuing therapy, and it removes the barriers of travel and scheduling, which matters in a spread-out metro like the Triangle. In-person care is often preferable for an initial psychiatric evaluation, for complex conditions, or when hands-on support matters, because a clinician can pick up on cues that are harder to read over video. NC Medicaid and most commercial insurers cover telehealth mental health visits, so cost is rarely the deciding factor. Many people use a mix: an in-person evaluation to start, then telehealth for follow-up once a relationship is established.

Insurance and Cost for Mental Health Treatment in Raleigh, NC

Most Raleigh clinics accept major commercial plans, including Blue Cross Blue Shield of North Carolina, Aetna, and Cigna/Evernorth, along with NC Medicaid managed-care plans like Alliance Health and Healthy Blue. Under the federal Mental Health Parity and Addiction Equity Act, plans that cover mental health must apply financial terms no more restrictive than those for medical care (CMS, MHPAEA).

Without insurance, therapy sessions in Raleigh typically run $100 to $200 per visit and psychiatry $200 to $400, as general ranges rather than quotes. Some practices offer sliding-scale fees based on income.

If you go out of network, ask the provider for a superbill, a detailed receipt you can submit to your insurer for partial reimbursement. Our patients and families resources can help you prepare, and you should confirm every figure with the clinic and your insurer before starting.

How to Find the Right Mental Health Clinic in Raleigh

A practical sequence:

1.  Identify what you need. Medication, therapy, or both? Your symptoms and daily functioning point to the level of care.

2.  Check insurance before booking. Confirm in-network status and your copay.

3.  Search by location, condition, and insurance. The Psychology Today therapist directory and SAMHSA’s FindTreatment.gov locator both filter on all three.

4.  Verify the provider’s license. You can confirm a clinician is licensed and in good standing through the North Carolina Medical Board or the NC Psychology Board.

5.  Ask about new-patient availability and telehealth. A shorter path to care matters when symptoms are acute.

If you want help thinking through which level of care fits, contact our team.

Getting Started

Finding the right clinic is the first step, and it does not have to be the hardest one. If you or someone you love is managing a serious or complex mental health condition in the Triangle, Amae Health’s Raleigh clinic offers integrated care with psychiatry, therapy, group therapy, peer support, and health coaching under one team. Explore our full range of treatments, or call (984) 849-4342 to talk with our intake team about whether Amae is the right fit for your situation.

Frequently Asked Questions

–  What is the best mental health clinic in Raleigh, NC? There is no single best clinic; it depends on your condition, the support you need, and your insurance. For complex or serious conditions, Amae Health offers integrated psychiatric care. For broad access across the Triangle, Mindpath Health is a large network, and for therapy-focused care, Ellie Mental Health is a strong option.

–  What is the difference between psychiatry and behavioral health? Behavioral health is the broader term, covering mental health and substance use services. Psychiatry is a medical specialty within behavioral health focused on diagnosis and medication management. Both terms are used in Raleigh to describe outpatient mental health care.

–  Does NC Medicaid cover mental health treatment in Raleigh? Yes. NC Medicaid covers outpatient mental health services, including therapy and psychiatry. Several Raleigh clinics accept Medicaid managed-care plans like Alliance Health and Healthy Blue. Confirm network status with the clinic before booking.

–  What is outpatient behavioral health treatment? Outpatient treatment means receiving psychiatric care or therapy while living at home. It ranges from weekly sessions to intensive outpatient programs (IOP). Most people start with standard outpatient care and adjust based on need.

–  How long does it take to get a mental health appointment in Raleigh? It varies by provider. Some clinics offer same-day or same-week appointments, while academic centers may take longer. For free, 24/7 support, contact the 988 Suicide and Crisis Lifeline at 988 by call or text.

–  How much does therapy cost in Raleigh, NC? With insurance, in-network copays typically run $0 to $50 per session. Without insurance, therapy is usually $100 to $200 per visit and psychiatry $200 to $400. Some practices offer sliding-scale fees, so confirm costs with the clinic directly.

–  Can I get mental health treatment in Raleigh without insurance? Yes. Many Raleigh clinics offer sliding-scale fees, NC Medicaid is available to eligible residents, and Federally Qualified Health Centers in Wake County see patients regardless of ability to pay.

Citations

1. SAMHSA, National Substance Use and Mental Health Services Survey (N-SUMHSS) Definitions: “Partial hospitalization/day treatment.” info.nsumhss.samhsa.gov/definitions.htm. Tier 2 (U.S. government).

2. National Institute of Mental Health, “Psychotherapies.” nimh.nih.gov/health/topics/psychotherapies. Tier 2 (U.S. government).

3. Centers for Medicare & Medicaid Services, “The Mental Health Parity and Addiction Equity Act (MHPAEA).” cms.gov. Tier 2 (U.S. government).

‍